Quality Improvement for Institutions
www.cvquality.acc.org

Cardiovascular Quality and Research News

ACC CV Quality SmartBrief

The ACC CV Quality SmartBrief eNewsletter is a free, twice-weekly briefing for health care stakeholders interested in quality care. Learn more about the ACC CV Quality SmartBrief and subscribe.

  • Types 1 and 2 diabetes may raise infection risks

    A study in the journal Diabetes found that people with type 1 diabetes had an 81% higher risk of infections treated by a healthcare professional and more than a threefold higher risk of being hospitalized for infection, compared with a control group. People with type 2 diabetes had a 51% higher risk of infections treated by a healthcare professional and nearly twice the risk of being hospitalized for infection. Pneumonia and other lower respiratory tract ailments were the most common infections related to the risk of hospitalization. HealthDay News (6/9) Learn More

  • Study: MRSA not tied to worse S. aureus bacteremia outcomes

    Methicillin resistance does not lead to worse short-term clinical outcomes in patients who have Staphylococcus aureus bacteremia, according to a study outlined at the ASM Microbe 2026 conference. The study, conducted at two Philadelphia hospitals, compared 143 patients with methicillin-resistant Staphylococcus aureus infections to 186 with methicillin-susceptible S. aureus, and found no significant difference in outcomes such as intensive care unit admission, length of hospital stay, readmission rates or in-hospital mortality. Dermatology Advisor (6/10) Learn More

  • Preventing CLABSIs requires systemic change, not perfection

    Central line-associated bloodstream infections remain a significant threat to patients and a financial burden for hospitals, despite being preventable. The challenge lies in the reliance on perfect human execution within imperfect systems. "The system we have in place for the prevention of CLABSI is clearly fragile and vulnerable to stress in the health care environment, particularly stress on the provider component of clinical care," said Dr. Naomi O'Grady of the National Institutes of Health Clinical Center. "We need to engineer resilient infection-prevention processes that can withstand changing environmental conditions and uncertain events." Infection Control Today (6/3) Learn More

  • Direct-to-patient drug platforms may come with pros, cons

    Direct-to-patient prescription drug programs are becoming more popular as a way to lower costs by bypassing insurers and pharmacy benefit managers, an analysis in JACC found. The platforms have gained traction following the president's executive order on drug pricing, with manufacturers introducing options for drugs such as semaglutide, apixaban and dapagliflozin. While DTP platforms could benefit uninsured patients and those with high-deductible plans, they may not offer significant savings for other insured patients, as DTP prices may be higher than negotiated rates, researchers wrote. Cardiovascular Business (6/10) Learn More

  • AI model improves cardiac arrest risk prediction

    Researchers at the University of Washington School of Medicine have developed an AI-enhanced model using ECGs and electronic health records to identify individuals at high risk for out-of-hospital cardiac arrest. Published in JACC: Advances, the study demonstrates that this model can predict cardiac arrest risk with greater accuracy, identifying a high-risk group with a 1% to 2% annual risk compared to the general population's 1 in 1,000 risk. Healio (free registration) (6/4) Learn More

  • Hospitalists aid digital transformation in healthcare

    Hospitalists are at the forefront of digital transformation in healthcare, leveraging their expertise to improve patient care through health informatics. As hospitals increasingly rely on electronic health records and digital tools, roles such as chief informatics officer and provider champions have emerged, allowing hospitalists to bridge clinical work with technological advancements. Medscape (6/8) Learn More

  • Maker gets FDA nod for rapid infection detection system

    Waters has received FDA 510(k) clearance for the BD Bactec FXI Culture System, which can reduce the mean time to detect bloodstream infections and sepsis by three hours compared with the previous generation. The system automates vial loading, incubation and detection, handling up to 60 vials at a time. 360Dx (tiered subscription model) (6/3) Learn More

Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006